Literature DB >> 10882057

Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice.

B N Dittel1, T H Urbania, C A Janeway.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model for the human autoimmune central nervous system (CNS) disease multiple sclerosis (MS). To examine the role of B cells in EAE with a relapsing and remitting disease course (R-EAE) we generated (B10.PL x SJL/J)F1 mice deficient in B cells by disrupting their mu heavy chain transmembrane region (B10.PL x SJL/J)F1 muMT-/-. By immunizing (B10.PL x SJL/J)F1 and (B10.PL x SJL/J)F1 muMT-/- mice with the encephalitogenic N-terminal peptide Acl-11 of myelin basic protein (MBP), we observed that B-cell deficient mice exhibited a relapsing and remitting disease course. Since a similar day of onset and day of first relapse were observed these data suggest that B cells do not play a vital role in the activation of T cells leading to the initiation of EAE, nor in the reactivation of T cells resulting in R-EAE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882057     DOI: 10.1006/jaut.2000.0371

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  20 in total

Review 1.  A biological context for the self-nonself discrimination and the regulation of effector class by the immune system.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Learning from a contemporary history of immunology.

Authors:  Melvin Cohn
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 3.  Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Avijit Ray; Sreemanti Basu; Christopher L Karp; Bonnie N Dittel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

Review 4.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Authors:  Andrew P Robinson; Christopher T Harp; Avertano Noronha; Stephen D Miller
Journal:  Handb Clin Neurol       Date:  2014

5.  ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.

Authors:  Ryder F Whittaker Hawkins; Alexandre Patenaude; Aline Dumas; Rajiv Jain; Yodit Tesfagiorgis; Steven Kerfoot; Takeshi Matsui; Matthias Gunzer; Patrice E Poubelle; Catherine Larochelle; Martin Pelletier; Luc Vallières
Journal:  JCI Insight       Date:  2017-12-07

6.  Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.

Authors:  Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

7.  Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Authors:  Shulamit Naor; Zohar Keren; Tomer Bronshtein; Efrat Goren; Marcelle Machluf; Doron Melamed
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

8.  A rationalized set of default postulates that permit a coherent description of the immune system amenable to computer modeling.

Authors:  M Cohn
Journal:  Scand J Immunol       Date:  2008-10       Impact factor: 3.487

9.  B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice.

Authors:  Jeri-Anne Lyons; Michael J Ramsbottom; Robert J Mikesell; Anne H Cross
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

10.  IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Authors:  Rebecca A Sosa; Cathi Murphey; Rachel R Robinson; Thomas G Forsthuber
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.